Aptose Biosciences ( NASDAQ: APTO ) said it has entered into a definitive agreement for the issuance and sale of 3.86M shares at $1.15 apiece in a direct offering.
Additionally, in a concurrent private placement, the company has agreed to issue unregistered series A warrants to purchase up to 3.86M shares and series B warrants to purchase up to 3.86M shares, each at an exercise price of $1.
15 per share. More on Aptose Biosciences Seeking Alpha’s Quant Rating on Aptose Biosciences Historical earnings data for Aptose Biosciences Financial information for Aptose Biosciences.
